Intensive Parent-child Interaction Therapy (I-PCIT): Feasibility and Effectiveness Study.

Overview

  • Study type

    Interventional
  • Study IDs

  • Describes the nature of a clinical study. Types include:

    • Observational study — observes people and measures outcomes without affecting results.
    • Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
    • Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
  • Site IRB
    • La Crosse, Wisconsin: 18-007475
    • Rochester, Minnesota: 18-007475
    Sponsor Protocol Number: 18-007475

About this study

The purpose of this study is to evaluate the feasibility of implementing I-PCIT in a community clinic, measured by treatment attendance and caregiver’s satisfaction compared to the current gold-standard of PCIT-au.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

See eligibility criteria

Inclusion Criteria:

  • Participants in I-PCIT and PCIT-au group will be enrolled from the outpatient Behavioral Health Clinic in La Crosse WI. 
  • Children, ages 2.5- 7 years old.
  • Children whose measure of EBP rated above the clinically significant range (T-score ≥ 60) on ECBI.
  • Eligible families will have to commit to a full course of treatment. 
  • Patients who have answered yes to research authorization.
  • Children of patients who have answered yes to research authorization.

Exclusion Criteria: 

  • Children with an intellectual disability, Autistic Disorder, or a psychotic disorder.
  • The inability of parents to attend sessions daily.
  • Patients that answered no to research authorization

Participating Mayo Clinic locations

Study statuses change often. Please contact us for help.

Mayo Clinic Location Status Contact

La Crosse, Wis.

Mayo Clinic principal investigator

Magdalena Romanowicz, M.D.

Open for enrollment

Contact information:

Chelsea Ale Ph.D., L.P.

(608)392-9555

Ale.Chelsea@mayo.edu

Rochester, Minn.

Mayo Clinic principal investigator

Magdalena Romanowicz, M.D.

Contact us for the latest status

Contact information:

Jennifer Inbarasu M.D.

(507)293-5522

Inbarasu.Jennifer@mayo.edu

.
CLS-20451082

Mayo Clinic Footer